Bausch + Lomb Corporation (BLCO) is a publicly traded Healthcare sector company. As of July 9, 2026, BLCO trades at $16.68 with a market cap of $6.10B and a P/E ratio of -26.78. BLCO moved +0.66% today. Year to date, BLCO is -2.46%; over the trailing twelve months it is +19.00%. Its 52-week range spans $10.45 to $20.71. Analyst consensus is neutral with an average price target of $18.29. Rallies surfaces BLCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BLCO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $16.68 |
| Market Cap | $6.10B |
| P/E Ratio | -26.78 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.71 |
| 52-Week Low | $10.45 |
| Volume | 24.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.21B |
| Net Income | $-211.00M |
| Gross Margin | 0.00% |
9 analysts cover BLCO: 0 strong buy, 3 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $18.29.